BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1969060)

  • 1. Inhibition of HIV progression by dithiocarb. German DTC Study Group.
    Reisinger EC; Kern P; Ernst M; Bock P; Flad HD; Dietrich M
    Lancet; 1990 Mar; 335(8691):679-82. PubMed ID: 1969060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study.
    Hersh EM; Brewton G; Abrams D; Bartlett J; Galpin J; Gill P; Gorter R; Gottlieb M; Jonikas JJ; Landesman S
    JAMA; 1991 Mar; 265(12):1538-44. PubMed ID: 1671884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection.
    Lang JM; Touraine JL; Trepo C; Choutet P; Kirstetter M; Falkenrodt A; Herviou L; Livrozet JM; Retornaz G; Touraine F
    Lancet; 1988 Sep; 2(8613):702-6. PubMed ID: 2901566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, randomized, placebo-controlled study of ditiocarb (Imuthiol) in human immunodeficiency virus-infected asymptomatic and minimally symptomatic patients. The HIV87 Study Group.
    AIDS Res Hum Retroviruses; 1993 Jan; 9(1):83-9. PubMed ID: 8094001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of diethyldithiocarbamate in patients with acquired immune deficiency syndrome (AIDS) and the AIDS-related complex.
    Brewton GW; Hersh EM; Rios A; Mansell PW; Hollinger B; Reuben JM
    Life Sci; 1989; 45(26):2509-20. PubMed ID: 2559272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled dose response study of intravenous sodium diethyldithiocarbamate in patients with advanced human immunodeficiency virus infection.
    Kaplan CS; Petersen EA; Yocum D; Hersh EM
    Life Sci; 1989; 45(22):iii-ix. PubMed ID: 2557513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of diethyldithiocarbamate (Ditiocarb, Imuthiol) in an animal model of retrovirus-induced immunodeficiency disease and in clinical trials in patients with HIV infection. The Ditiocarb Study Group.
    Hersh EM; Funk CY; Petersen EA; Mosier DE
    Dev Biol Stand; 1990; 72():355-63. PubMed ID: 2178128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic properties of sodium diethyldithiocarbamate: its role as an inhibitor in the progression of AIDS.
    Sunderman FW
    Ann Clin Lab Sci; 1991; 21(1):70-81. PubMed ID: 1849385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial.
    Katabira ET; Sewankambo NK; Mugerwa RD; Belsey EM; Mubiru FX; Othieno C; Kataaha P; Karam M; Youle M; Perriens JH; Lange JM
    Sex Transm Infect; 1998 Aug; 74(4):265-70. PubMed ID: 9924466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased plasma membrane fluidity of peripheral blood lymphocytes after diethyldithiocarbamate (DTC) therapy in HIV-infected patients.
    Lehr HA; Zimmer JP; Hübner C; Reisinger EC; Kohlschütter A; Claussen M; Schmitz H; Dietrich M
    Eur J Clin Pharmacol; 1989; 37(5):521-3. PubMed ID: 2557220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter clinical trial of oral ribavirin in HIV-infected patients with lymphadenopathy. The Ribavirin-LAS Collaborative Group.
    Roberts RB; Dickinson GM; Heseltine PN; Leedom JM; Mansell PW; Rodriguez S; Johnson KM; Lubina JA; Makuch RW
    J Acquir Immune Defic Syndr (1988); 1990; 3(9):884-92. PubMed ID: 1974628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous immunoglobulins in HIV-1-infected adults with AIDS-related complex and Walter-Reed 5.
    Schrappe-Bächer M; Rasokat H; Bauer P; Bendick C; Bube FW; Degenhardt S; Fätkenheuer G; Heiniger HJ; Heitmann K; Imbach P
    Vox Sang; 1990; 59 Suppl 1():3-14. PubMed ID: 1978443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Concorde Coordinating Committee.
    Lancet; 1994 Apr; 343(8902):871-81. PubMed ID: 7908356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV infection. Dithiocarb treatment in AIDS is unsuccessful].
    Fortschr Med; 1991 Nov; 109(33):18. PubMed ID: 1663068
    [No Abstract]   [Full Text] [Related]  

  • 15. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albendazole chemotherapy for treatment of diarrhoea in patients with AIDS in Zambia: a randomised double blind controlled trial.
    Kelly P; Lungu F; Keane E; Baggaley R; Kazembe F; Pobee J; Farthing M
    BMJ; 1996 May; 312(7040):1187-91. PubMed ID: 8634560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased counts of blood neutrophils, monocytes, and platelets in human immunodeficiency virus-infected children and young adults treated with diethyldithiocarbamate.
    Shenep JL; Hughes WT; Flynn PM; Roberson PK; Behm FG; Fullen GH; Kovnar SG; Guito KP; Brodkey TO
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1644-6. PubMed ID: 7979299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extended therapeutic role of dithiocarb (sodium diethyldithiocarbamate) from nickel poisoning to AIDS.
    Sunderman FW
    Ann Clin Lab Sci; 1992; 22(4):245-8. PubMed ID: 1323945
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
    Hersh EM; Funk CY; Ryschon KL; Petersen EA; Mosier DE
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):553-61. PubMed ID: 1657074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.